Alzheimer's disease & dementia

Aduhelm: Will Medicare cover the controversial Alzheimer's drug?

(HealthDay)—Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial Alzheimer's drug Aduhelm. The drug's ...

Diseases, Conditions, Syndromes

Patient mortality lower for hospitalists working more days

(HealthDay)—Hospitalized Medicare patients treated by physicians who work more clinical days have lower 30-day mortality, according to a study published online Sept. 13 in JAMA Internal Medicine.

page 6 from 33